Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen. - Wikidata - awgldk - TriplyDB

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.

http://www.wikidata.org/entity/Q37835358

about

Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.Update on Chlamydia trachomatis Vaccinology.

P2860

Q33757880-39965D95-A10C-487D-A519-3DE3D47765BC Q37742680-486B36BD-0EA5-43BA-810B-AD72D915995A Q37834874-449023CD-5175-4A51-84E4-94D0236AA5B1

P2860

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.

http://www.wikidata.org/entity/Q37835358

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@en

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@nl

type

label

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@en

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@nl

prefLabel

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@en

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@nl

P1433

Q37835358-79245668-EB6B-4A27-AFF3-FE288FD313AF

P1476

Q37835358-DF547C60-6CB9-48C2-B268-F366C236D84B

P2093

Q37835358-2C55599F-D4F4-47AC-BC92-0B6E78F30D60

Q37835358-2CB04483-4226-49E6-9F3E-B11E1A782849

Q37835358-4BD79224-F9E4-491D-84EB-477BB26B222A

Q37835358-5717ABB9-5778-481E-BA48-CF090F2A55EC

Q37835358-582A346A-D4DF-4C7A-B63B-E2F12BF4CFE4

Q37835358-7707FAE2-E77D-4A22-9914-CE9238878620

P2860

Q37835358-048AA942-7713-4BEB-9DEE-DB8095D421C3

Q37835358-0D822CDC-A409-47CD-A324-584EFFF95EEA

Q37835358-0E764E4A-347E-4B07-BEA7-0EE850BD97B3

Q37835358-20D2BAA2-D2D9-4AA9-AD20-BC9189095832

Q37835358-2EA9A891-AA06-475A-93EC-03B0EB48DED6

Q37835358-36CE4FEE-BE68-445F-A26F-FA71BD8E1EDE

Q37835358-3ACFF45A-305A-4248-92DB-89254C561543

Q37835358-49FBA714-1FB1-46F7-AE64-9C957F9AE5F3

Q37835358-4FF9D207-4F0B-4AF4-8FD2-2E18BC8D2EF7

Q37835358-52B27728-8743-4C5A-8173-0D44E6F1921F

P304

Q37835358-B468C199-0514-49F4-B714-7D1BF603F5D4

P31

Q37835358-7084B7F3-43BB-46A1-A123-02CB136B5791

P356

Q37835358-B64795C2-98E5-4F49-9019-D0C3B1C0AE48

P433

Q37835358-BAA45234-CCE3-457A-B272-6C89315C4A19

P478

Q37835358-CDF5C534-FFD4-46F9-8700-91E1E7E81D06

P50

Q37835358-22FC5BD5-D9FC-4BBD-ABF1-10C853143B54

Q37835358-BF49D51A-838E-4AF1-9A4E-A25D9683A38D

P577

Q37835358-A8E33970-67D9-4534-BB2A-44F617C64E55

P698

Q37835358-2CF4837D-A7E1-41F3-BF2B-873CD4D01180

P921

Q37835358-622C97EE-A11F-4ACF-A4C1-97DA3DA6A58F

Q37835358-C98F0E7C-B0CD-43BE-80BA-006ACE9D0EC6

P356

P1433

Acta Pathologica et Microbiologica Scandinavica

P1476

Protection against genital tra ...... ecombinant MOMP VS2/4 antigen.

@en

P2093

Ellen Marks

http://www.w3.org/2001/XMLSchema#string

Irina Kalbina

http://www.w3.org/2001/XMLSchema#string

Karin Schön

http://www.w3.org/2001/XMLSchema#string

Ronza Hadad

http://www.w3.org/2001/XMLSchema#string

Sören Andersson

http://www.w3.org/2001/XMLSchema#string

Åke Strid

http://www.w3.org/2001/XMLSchema#string

P2860

T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans

Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis Major Outer Membrane Protein

Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome.

Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.

Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.

Immunology of the human genital tract.

Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Public health policies and management strategies for genital Chlamydia trachomatis infection.

P304

1078-1086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APM.12605

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27859689

http://www.w3.org/2001/XMLSchema#string

P921

Chlamydia trachomatis